Alterity Therapeutics Ltd. ( (AU:ATH) ) has provided an announcement.
Alterity Therapeutics Ltd. has announced a prospectus offering new options to selected participants, including a placement offer and a broker offer. The options, which have an exercise price of A$0.028 and expire in February 2027, aim to raise capital and potentially strengthen the company’s financial position, impacting its future operations and market strategy.
More about Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. operates in the biotechnology industry, focusing on developing therapeutic drugs. The company is involved in creating treatments for neurodegenerative diseases, with a particular emphasis on disorders such as Alzheimer’s and Parkinson’s diseases.
Average Trading Volume: 550
Technical Sentiment Signal: Buy
Current Market Cap: $40.56M
See more insights into ATH stock on TipRanks’ Stock Analysis page.